Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Embolism Cardiovascular Diseases Embolism Embolism and Thrombosis Lung Diseases Respiratory Tract Diseases Vascular Diseases

Age range

18 year–110 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nice University Hospital

Nice, 06000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All pulmonary embolisms hospitalised in Nice hospital.
acceptation to enter in the cohorte survey

Exclusion criteria

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

Reccurence

Time frame: 10 years

number of patient with Documented symptomatic pulmonary embolism reccurence

Secondary outcomes

Pulmonary hypertension

Time frame: 10 years

number of patients with Confirmed pulmonary hypertension after pulmonary embolism
Chronic pulmonary disease without hypertension

Time frame: 10 years

number of patients with dyspnea but without pulmonary hypertension, Documented non-reperfused pulmonary areas

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

Pulmonary Embolism Registry

Acronym: REMATEV

Important dates

Study start: 1992
Primary completion: 1997
Study completion: 1997
First posted: Jul 28, 2021
Registry last updated: Mar 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed